Cv Sciences Inc Down 3.28% To $0.03 After Earnings

Cv Sciences Inc (CVSI) said before open Tuesday that it broke even in quarter three 2023. The company reported earnings on an adjusted basis, so it may not be directly comparable to analyst estimates or prior periods. The company reported $4.1 million in revenue

In the same quarter a year ago, the company lost $0.01 per share on revenue of $3.8 million.

The stock is down 3.28% to $0.03 after the report.

Despite revenues increasing, earnings decreased, signaling a decline in profit margins.

InvestorsObserver gives the stock a Bearish Sentiment score at the moment based on recent trading.

Prior to the report, InvestorsObserver gave the stock an overall score of 8.

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.